Apellis Pharmaceuticals Inc (APLS)
47.47
+1.44
(+3.13%)
USD |
NASDAQ |
May 02, 16:00
47.47
0.00 (0.00%)
After-Hours: 18:05
Apellis Pharmaceuticals Market Cap: 5.724B for May 2, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 01, 2024 | 5.550B |
| April 30, 2024 | 5.329B |
| April 29, 2024 | 5.769B |
| April 26, 2024 | 6.012B |
| April 25, 2024 | 5.779B |
| April 24, 2024 | 6.021B |
| April 23, 2024 | 5.875B |
| April 22, 2024 | 5.745B |
| April 19, 2024 | 5.731B |
| April 18, 2024 | 5.729B |
| April 17, 2024 | 5.792B |
| April 16, 2024 | 6.249B |
| April 15, 2024 | 6.210B |
| April 12, 2024 | 6.245B |
| April 11, 2024 | 6.720B |
| April 10, 2024 | 6.854B |
| April 09, 2024 | 6.646B |
| April 08, 2024 | 6.489B |
| April 05, 2024 | 6.742B |
| April 04, 2024 | 6.759B |
| April 03, 2024 | 6.867B |
| April 02, 2024 | 6.716B |
| April 01, 2024 | 7.200B |
| March 28, 2024 | 7.088B |
| March 27, 2024 | 7.053B |
| Date | Value |
|---|---|
| March 26, 2024 | 7.114B |
| March 25, 2024 | 6.696B |
| March 22, 2024 | 6.679B |
| March 21, 2024 | 6.826B |
| March 20, 2024 | 6.695B |
| March 19, 2024 | 6.864B |
| March 18, 2024 | 6.784B |
| March 15, 2024 | 6.842B |
| March 14, 2024 | 6.810B |
| March 13, 2024 | 6.917B |
| March 12, 2024 | 7.054B |
| March 11, 2024 | 7.318B |
| March 08, 2024 | 7.431B |
| March 07, 2024 | 7.529B |
| March 06, 2024 | 7.348B |
| March 05, 2024 | 7.533B |
| March 04, 2024 | 7.793B |
| March 01, 2024 | 7.704B |
| February 29, 2024 | 7.472B |
| February 28, 2024 | 7.723B |
| February 27, 2024 | 8.362B |
| February 26, 2024 | 8.649B |
| February 23, 2024 | 8.256B |
| February 22, 2024 | 8.150B |
| February 21, 2024 | 8.066B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.138B
Minimum
May 17 2019
10.87B
Maximum
Jun 13 2023
4.502B
Average
4.204B
Median
Market Cap Benchmarks
| Sarepta Therapeutics Inc | 12.24B |
| Blueprint Medicines Corp | 6.553B |
| Alnylam Pharmaceuticals Inc | 18.91B |
| Ionis Pharmaceuticals Inc | 6.287B |
| Madrigal Pharmaceuticals Inc | 4.298B |
Market Cap Related Metrics
| PS Ratio | 14.21 |
| Price to Book Value | 29.43 |
| Price | 47.47 |
| Earnings Yield | -9.44% |